A single institution retrospective review of efficacy, toxicity, and symptom burden in patients (pts) with pancreatic cancer (PaC) receiving FOLFIRINOX chemotherapy.
James Traquair Paul
No relevant relationships to disclose
Pascal J Lambert
No relevant relationships to disclose
Joel Roger Gingerich
No relevant relationships to disclose
Piotr Czaykowski
No relevant relationships to disclose
Paul Joseph Daeninck
No relevant relationships to disclose